SCHEMBL3334570

SCHEMBL3334570

Nc1ccccc1Oc1nc(Cl)ncc1Cl

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PIN1 Q13526 9/20 0.64
▸ CYP1A2 P05177 1/20 0.52
▸ CYP3A4 P08684 1/20 0.52
▸ CYP2C19 P33261 1/20 0.52
▸ EGFR P00533 1/20 0.45
▸ ALDH1A1 P00352 3/20 0.41
▸ GAA P10253 1/20 0.40
▸ RCE1 Q9Y256 1/20 0.40
▸ ADRA2B P18089 1/20 0.40
▸ PTGS1 P23219 1/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ MAPT P10636 2/20 0.40
▸ HTT P42858 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ CRHBP P24387 1/20 0.40
▸ CRHR2 Q13324 1/20 0.40
▸ MEN1 O00255 1/20 0.39
▸ LMNA P02545 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ IKBKB O14920 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30635855 1.00 PIN1 (0.64) PIN1CYP1A2CYP3A4CYP2C19EGFR
SCHEMBL25947633 0.82 PIN1 (0.46) PIN1CYP1A2CYP2C19ALDH1A1HTT
SCHEMBL30378947 0.81 LCK (0.46) PIN1ALDH1A1GAAMAPTHTT
SCHEMBL26087125 0.81 LCK (0.46) PIN1ALDH1A1GAAMAPTHTT
Phosphine SCHEMBL25950886 0.78 PIN1 (0.46) PIN1ALDH1A1GAAHTTKDM4E
SCHEMBL29596360 0.76 PIN1 (0.64) PIN1ALDH1A1GAAMAPTHTT
SCHEMBL22895754 0.76 PIN1 (0.64) PIN1ALDH1A1GAAMAPTHTT
SCHEMBL30875696 0.76 PIN1 (0.44) PIN1ALDH1A1HTT
SCHEMBL18812797 0.76 PIN1 (0.44) PIN1ALDH1A1HTT
SCHEMBL3332690 0.75 PIN1 (0.66) PIN1EGFRALDH1A1GAAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100144732-A1 PYRIMIDINE KINASE INHIBITORS GENENTECH, INC. 2010-06-10 — — US disclosed
US-20100144732-A1 PYRIMIDINE KINASE INHIBITORS GENENTECH, INC. 2010-06-10 — — US disclosed
US-20100144732-A1 PYRIMIDINE KINASE INHIBITORS GENENTECH, INC. 2010-06-10 — — US disclosed
EP-2099771-A1 PYRIMIDINE KINASE INHIBITORS Genentech, Inc. (US) 2009-09-16 — — EP disclosed
WO-2008079719-A1 PYRIMIDINE KINASE INHIBITORS GENENTECH, INC. (US) 2008-07-03 — — WO disclosed
WO-2008079719-A1 PYRIMIDINE KINASE INHIBITORS GENENTECH, INC. (US) 2008-07-03 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100144732-A1 PYRIMIDINE KINASE INHIBITORS DTYMK, DCK, TYMP PIN1 2781/4885CYP1A2 3395/4885CYP3A4 3096/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback